Producción científica por año
Producción científica por año
Huella digital
Profundizar en los temas de investigación en los que Daohong Zhou está activo. Estas etiquetas de temas provienen de las obras de esta persona. Juntos, forma una huella digital única.
- 1 Perfiles similares
Colaboraciones y áreas de investigación principales de los últimos cinco años
Colaboración externa reciente a nivel de país/territorio. Para consultar los detalles, haga clic en los puntos o
-
A BCL-xL/BCL-2 PROTAC effectively clears senescent cells in the liver and reduces MASH-driven hepatocellular carcinoma in mice
Yang, Y., Jn-Simon, N., He, Y., Sun, C., Zhang, P., Hu, W., Tian, T., Zeng, H., Basha, S., Huerta, A. S., Sun, L. Z., Yin, X. M., Hromas, R., Zheng, G., Pi, L. & Zhou, D., mar 2025, En: Nature Aging. 5, 3, p. 386-400 15 p., 15691.Producción científica: Article › revisión exhaustiva
13 Citas (Scopus) -
A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR
Han, S., Tushoski-Alemán, G. W., Zhang, P., Zheng, G., Zhou, D., Huo, Z., Licht, J., George, T. J., Allegra, C., Trevino, J. G. & Hughes, S. J., ene 2025, En: Neoplasia (United States). 59, 101070.Producción científica: Article › revisión exhaustiva
Acceso abierto3 Citas (Scopus) -
A Senescent Cluster in Aged Human Hematopoietic Stem Cell Compartment as Target for Senotherapy
Poisa-Beiro, L., Landry, J. J. M., Yan, B., Kardorff, M., Eckstein, V., Villacorta, L., Krammer, P. H., Zaugg, J., Gavin, A. C., Benes, V., Zhou, D., Raffel, S. & Ho, A. D., ene 2025, En: International journal of molecular sciences. 26, 2, 787.Producción científica: Article › revisión exhaustiva
Acceso abierto2 Citas (Scopus) -
CD36-mediated endocytosis of proteolysis-targeting chimeras
Wang, Z., Pan, B. S., Manne, R. K., Chen, J., Lv, D., Wang, M., Tran, P., Weldemichael, T., Yan, W., Zhou, H., Martinez, G. M., Shao, J., Hsu, C. C., Hromas, R., Zhou, D., Qin, Z., Lin, H. K. & Li, H. Y., jun 12 2025, En: Cell. 188, 12, p. 3219-3237.e18Producción científica: Article › revisión exhaustiva
17 Citas (Scopus) -
CTC1-STN1-TEN1 controls DNA break repair pathway choice via DNA end resection blockade
Rogers, C. M., Kaur, H., Swift, M. L., Raina, V. B., Zhou, S., Kawale, A. S., Syed, S., Kelly, K. G., Jasper, A. M., Salunkhe, S., Kwon, Y., Wang, J., Shabestari, A. B., Daley, J. M., Sacks, A., Gaczynska, M. E., Osmulski, P. A., Rawal, Y., Tomimatsu, N. & Gayther, S. A. y 12 otros, , may 22 2025, En: Science. 388, 6749, p. 881-888 8 p.Producción científica: Article › revisión exhaustiva
3 Citas (Scopus)
Conjuntos de datos
-
Cryo-EM structure of the human BCDX2 complex
Rawal, Y. (Contributor), Jia, L. (Contributor), Meir, A. (Contributor), Zhou, S. (Contributor), Kaur, H. (Contributor), Ruben, E. A. (Contributor), Kwon, Y. (Contributor), Bernstein, K. A. (Contributor), Jasin, M. (Contributor), Taylor, A. B. (Contributor), Burma, S. (Contributor), Hromas, R. (Contributor), Mazin, A. V. (Contributor), Zhao, W. (Contributor), Zhou, D. (Contributor), Wasmuth, E. V. (Contributor), Greene, E. C. (Contributor), Sung, P. (Contributor) & Olsen, S. K. (Contributor), Protein Data Bank (PDB), jun 21 2023
DOI: 10.2210/pdb8FAZ/pdb, https://www.wwpdb.org/pdb?id=pdb_00008faz
Dataset
-
Additional file 3 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726550.v1, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726550/1
Dataset
-
Additional file 2 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726547.v1, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726547/1
Dataset
-
Additional file 3 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726550, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726550
Dataset
-
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5075029.v1, https://springernature.figshare.com/collections/Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/5075029/1
Dataset